Conditioning neoadjuvant therapies for improved immunotherapy of cancer

Recent advances in the treatment of melanoma and non-small cell lung cancer (NSCLC) by combining conventional therapies with anti-PD1/PD-L1 immunotherapies, have renewed interests in immunotherapy of cancer. The emerging concept of conventional cancer therapies combined with immunotherapy differs fr...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Biochem Pharmacol
Main Authors: Benson, Zachary, Manjili, Saeed H., Habibi, Mehran, Guruli, Georgi, Toor, Amir A, Payne, Kyle K., Manjili, Masoud H.
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5681417/
https://ncbi.nlm.nih.gov/pubmed/28803721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2017.08.007
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki